Latest News about JNJ
Recent news which mentions JNJ
From InvestorPlace
From Motley Fool
From InvestorPlace
Johnson & Johnson Faces MedTech Challenges But Is 'On Track' To Meet 2024 Guidance: Goldman Sachs
July 09, 2024
From Benzinga
Emergent BioSolutions And Johnson & Johnson Resolve Claims Over COVID-19 Vaccine Manufacturing
July 09, 2024
From Benzinga
7 Diversified Income Powerhouses for Lifelong Cash Flow
July 08, 2024
From InvestorPlace
3 Rock-Solid Income Machines to Hold for Decades
July 05, 2024
From InvestorPlace
From InvestorPlace
What's Going On With Johnson and Johnson Shares Friday?
July 05, 2024
From Benzinga
From InvestorPlace
Upcoming Stock Spinoffs: Should You Pounce or Pass?
July 04, 2024
From InvestorPlace
7 Blue-Chip Cash Cows to Milk for Steady Income
July 03, 2024
From InvestorPlace
From InvestorPlace
From InvestorPlace
Johnson & Johnson's Cell Therapy Carvykti Shows Better Survival Rate In Pretreated Blood Cancer Patients
July 02, 2024
From Benzinga
From Benzinga
5 Biggest Winners, 5 Biggest Losers From Dow Jones Industrial Average In First Half 2024
July 01, 2024
From Benzinga
From Motley Fool
3 Retirement All-Stars for Steady Growth and Income
July 01, 2024
From InvestorPlace
From InvestorPlace
Assessing Johnson & Johnson's Performance Against Competitors In Pharmaceuticals Industry
July 01, 2024
From Benzinga
From Benzinga
3 Magnificent Stocks Retirees Can Buy and Hold Forever
July 01, 2024
From Motley Fool
From InvestorPlace
From InvestorPlace
From Motley Fool
4 Cheap Stocks to Buy in July
June 29, 2024
From Motley Fool
Wall Street's Most Accurate Analysts Give Their Take On 3 Health Care Stocks With Over 3% Dividend Yields
June 28, 2024
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.